Search - tctmd.com

Displaying 421 - 440 of 612

Sort: Relevancy | Date

News Daily News

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

September 20, 2013

News Industry News

Boston Scientific Concludes Enrollment In Randomized, Multicenter, Pivotal Study Of SYNERGY™ Coronary Stent System

September 12, 2013

News Daily News

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

Caitlin E. Cox

August 30, 2013

News Daily News

Meta-analysis: DES More Effective Than BMS for STEMI with No Safety Trade-off

L.A. McKeown

August 19, 2013

News Daily News

Contemporary ZES Perform Well in Treating In-Stent Restenosis

August 14, 2013

News Daily News

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

August 08, 2013

News Industry News

First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich’s COMBO Dual Therapy Stent™ in Routine Practice

August 06, 2013

News Daily News

Covered Stent Shows Promise in Treating Long SFA Lesions

L.A. McKeown

July 19, 2013

News Daily News

Drug-Eluting Balloons Lower TLR in Diabetics with Critical Limb Ischemia

Jason Kahn

July 05, 2013

News Daily News

PTA-First Strategy Matches Primary Stenting for Popliteal Artery Disease

Caitlin E. Cox

June 28, 2013

News Daily News

Japanese Registry Finds No Mortality Benefit with CTO PCI Even When Successful

Caitlin E. Cox

June 20, 2013

News Industry News

AngioScore Announces Completion of Enrollment in Drug-Coated AngioSculpt® Scoring Balloon Catheter First-in-Human Study

June 19, 2013

News Industry News

Micell Technologies Receives CE Mark Approval for MiStent SES

June 12, 2013

News Conference News EuroPCR 2013

ORBIT II: Atherectomy System Shows Positive Results in Calcified Lesions

Jason Kahn

May 24, 2013

News Industry News

Medtronic's In.Pact Falcon Drug-Eluting Balloon Yields Positive Outcomes in Small Coronary Arteries

May 23, 2013

News Industry News

For Bifurcation Lesions in Coronary Arteries, Medtronic's Resolute Stent Delivers Strong Long-Term Results

May 22, 2013

News Industry News

Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data

May 22, 2013

News Industry News

Elixir Medical Announces FDA Approval to Commence EXCELLA III Clinical Trial with DESyne® Nx Novolimus Eluting Coronary Stent System in the United States

May 08, 2013

News Daily News

TWENTE: Still Few Differences between ZES and EES at 2 Years

L.A. McKeown

May 03, 2013

News Daily News

Meta-analysis: DES Beneficial But May Not Save Limbs, Improve Survival in PAD Patients

May 03, 2013

Advertisement

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

Boston Scientific Concludes Enrollment In Randomized, Multicenter, Pivotal Study Of SYNERGY™ Coronary Stent System

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

Meta-analysis: DES More Effective Than BMS for STEMI with No Safety Trade-off

Contemporary ZES Perform Well in Treating In-Stent Restenosis

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich’s COMBO Dual Therapy Stent™ in Routine Practice

Covered Stent Shows Promise in Treating Long SFA Lesions

Drug-Eluting Balloons Lower TLR in Diabetics with Critical Limb Ischemia

PTA-First Strategy Matches Primary Stenting for Popliteal Artery Disease

Japanese Registry Finds No Mortality Benefit with CTO PCI Even When Successful

AngioScore Announces Completion of Enrollment in Drug-Coated AngioSculpt® Scoring Balloon Catheter First-in-Human Study

Micell Technologies Receives CE Mark Approval for MiStent SES

ORBIT II: Atherectomy System Shows Positive Results in Calcified Lesions

Medtronic's In.Pact Falcon Drug-Eluting Balloon Yields Positive Outcomes in Small Coronary Arteries

For Bifurcation Lesions in Coronary Arteries, Medtronic's Resolute Stent Delivers Strong Long-Term Results

Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data

Elixir Medical Announces FDA Approval to Commence EXCELLA III Clinical Trial with DESyne® Nx Novolimus Eluting Coronary Stent System in the United States

TWENTE: Still Few Differences between ZES and EES at 2 Years

Meta-analysis: DES Beneficial But May Not Save Limbs, Improve Survival in PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content